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Programmed cell death (PCD) is essential for normal development and maintenance of tissue homeostasis in multicellular organisms.
While it is now evident that PCD can take many different forms, apoptosis is probably the most well-defined cell death programme. The
characteristic morphological and biochemical features associated with this highly regulated form of cell death have until recently been
exclusively attributed to the caspase family of cysteine proteases. As a result, many investigators affiliate apoptosis with its pivotal execution
system, i.e. caspase activation. However, it is becoming increasingly clear that PCD or apoptosis can also proceed in a caspase-independent
manner and maintain key characteristics of apoptosis. Mitochondrial integrity is central to both caspase-dependent and-independent cell
death. The release of pro-apoptotic factors from the mitochondrial intermembrane space is a key event in a cell’s commitment to die and is
under the tight regulation of the Bcl-2 family. However, the underlying mechanisms governing the efflux of these pro-death molecules are
largely unknown. This review will focus on the regulation of mitochondrial integrity by Bcl-2 family members with particular attention to the
controlled release of factors involved in caspase-independent cell death.
D 2003 Elsevier B.V. All rights reserved.Keywords: Bcl-2 family; Mitochondrion; Apoptosis; Caspase-independent; AIF1. Caspase dependence of apoptosis
This family of intracellular proteases was first implicated
in apoptosis by genetic analysis in the nematode, Caeno-
rhabditis elegans, with the identification of ced3 and ced4,
cell death genes essential for developmental apoptosis [1].
Ced3 encodes a caspase that is activated by the upstream
‘trigger’ced4 resulting in the death of 131 cells of the 1090
generated during normal development [2,3]. The critical
role of both ced3 and ced4 in apoptosis is well established.
C. elegans mutants lacking either ced3 or ced4 or carrying
loss of function mutations have a complete absence of
developmental cell death [2]. To date, seven caspases have
been identified in the fruit fly, Drosophila melanogaster,
drICE, DCP-1, DCP-2/DREDD, Dronc, Decay, Strica/
Dream and Damm/Daydream [4]. At least DCP-1 is essen-
tial for early Drosophila development as deletion of DCP-10167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.08.011
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E-mail address: t.cotter@ucc.ie (T.G. Cotter).causes larval lethality and promotes melanotic tumour
development [5]. Caspases therefore appear to play a
crucial role in developmental apoptosis in both Drosophila
and C. elegans.
A more complex network of apoptotic machinery has
evolved in higher organisms. Since the recognition that
ced3 has sequence identity with the mammalian cysteine
protease interleukin-1-converting enzyme (ICE), a family
of at least 13 related cysteine proteases has been identified
in mammals, existing in the cell as inactive precursors that
undergo proteolytic processing and activation. Once acti-
vated, initiator caspases can proteolyse additional effector
caspases, generating a proteolytic cascade that cleaves key
structural components as well as proteins critical for cell
survival in a highly sequence-specific fashion, ultimately
resulting in the systemic and controlled destruction of the
cell. At least two major pathways of caspase activation
have been characterised. The extrinsic, receptor-mediated
pathway entails ligand binding to cell surface receptors,
receptor oligomerisation and recruitment and activation of
initiator caspases such as caspase-8, and the mitochondrial
pathway involving caspase activation from within the cell.
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family and initiated by release of cytochrome c and Smac/
Diablo from the mitochondrial intermembrane space. Cy-
tochrome c associates with Apaf-1 to promote the activa-
tion of caspase-9 which can then activate effector caspases,
while Smac/Diablo functions by binding to the inhibitors
of apoptosis proteins (IAPs) thereby disrupting their ability
to inhibit caspases 3, 7, and 9 [6,7]. The caspase cascade
may also be initiated at the endoplasmic reticulum (ER)
through activation of caspase-12 following ER stress. Very
little is currently known regarding the consequences of
caspase-12 activation, although it has recently been
reported that at least in vitro recombinant caspase-12
cleaves and activates procaspase-9. ER stress therefore
may induce a caspase cascade involving activation of
caspase-9 independently of cytochrome c release [8].
Interestingly, this pathway is also regulated by Bcl-2
proteins [9].Table 1
Examples of caspase-independent cell death
Cell death stimulus Cell type Reference
Tumour necrosis factor
alpha (TNF-alpha)
Human neutrophils [133]
Vitamin D compounds Breast cancer cells
(MCFV7’s)
[134]
Depletion of heat shock
protein 70
Breast cancer cells [135]
UVB Jurkat T cells [99]
HIV-1 infection Primary CD4+ T cells [136]
Tumour suppressor gene
ARHI
Ovarian and Breast cancer
cells
[137]
Bax PC12 cells (neuronal cell
line)
[138]
Ras Human glioma and gastric
cancer cells
[139]
Staurosporine L1210/0 cells [140]
Dexamethasone Dendritic cells [141]
Differentiation-inducing
factor, (DIF)
Insulin-secreting INS-1
cells
[142]
Inhibition of nuclear
factor kappaB
(NFkappaB)
Human T lymphocytes [143]
AIF Apaf-1 /  or
caspase-3 /  cells
[81,92]
Cathepsin inhibition Human leukaemia and
lymphoma cells
[144]
Cross-linking of several
surface receptors
including CD2, CD4,
CD45, CXCR4 and
CD99
CD4+ T cells, Human
peripheral T lymphocytes,
CD4 +CD8+ thymocytes
and Ewing’s sarcoma cells
[145–148]
Oxidative stress Retinal cells [149]
Hydroxyl radical Human tumour cells [150]
Nitric oxide PC12 and HeLa cells [151]
Thymocyte development Thymocytes [152]
Light Mouse photoreceptor cells
in vivo
[11]
Mutation in Rod cGMP
phosphodiesterase
Mouse photoreceptor cells
in vivo
[10]There is no doubt that caspases play a central role in
many apoptotic systems and that many of the typical
morphological features associated with apoptosis such as
internucleosomal DNA fragmentation, as well as membrane
blebbing and apoptotic body formation can be orchestrated
by caspase activation. It would be somewhat naive, howev-
er, to believe that caspases are indispensable for
programmed cell death (PCD). Emerging evidence from
an increasing number of experimental systems supports the
belief that apoptosis can occur independently of caspase
activation (Table 1). Cell death in these systems often occurs
with only partial condensation of chromatin and without
internucleosomal DNA fragmentation, but maintains many
other features of apoptosis, such as cytoplasmic and nuclear
shrinkage, mitochondrial depolarisation, membrane bleb-
bing, and externalisation of phosphatidylserine. Further-
more, this laboratory has recently described caspase-
independent apoptosis in three different in vivo models of
retinal degeneration, all of which display internucleosomal
DNA fragmentation [10,11]. Evidence from the above
studies supports the concept that cell death can proceed in
a caspase-independent manner while maintaining key char-
acteristics of apoptosis.
Further support for the existence of caspase-independent
apoptosis comes from studies on yeast. Yeasts lack homo-
logues of ced3, ced4, ced9 and caspase coding sequences in
their genome, yet still undergo PCD under conditions of
stress [12]. Moreover, a Saccharomyces cerevisiae cdc 48
cell cycle mutant has been described that results in cell death
featuring membrane blebbing, chromatin condensation and
fragmentation, and phosphatidylserine exposure [13]. This
yeast mutant provides strong evidence that some cytoplas-
mic and nuclear hallmarks of apoptosis can occur indepen-
dently of caspases.2. Bcl-2 proteins and caspase-independent apoptosis
So what is responsible for apoptotic-like features in
cells where caspase activation is not detected or where
caspase inhibitors have been employed? Several candi-
dates, which are capable of exerting at least some of these
features, reside within the mitochondrion. These include
apoptosis inducing factor (AIF), endonuclease G (endoG)
and Omi/HtrA2 (discussed in detail later). While it
remains elusive as to how exactly these proteins are
released from mitochondria, their discharge requires per-
meabilisation of the OMM, an event that is under the tight
control of the Bcl-2 family. This family consists of both
pro- and anti-apoptotic members that elicit opposing
effects on mitochondria. Pro-apoptotic members can in-
duce mitochondrial membrane permeability, which results
in the release of these factors, while anti-apoptotic mem-
bers such as Bcl-2 preserve mitochondrial integrity and
therefore potentially block the release of these soluble
intermembrane proteins.
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domains (BH) corresponding to a helical segments and can
be divided into three categories:
(1) The multi-domain pro-apoptotic members such as Bax,
Bok and Bak comprised of BH1, BH2 and BH3 domains.
(2) The ‘BH3-only’ pro-apoptotic members such as Bid,
Bik, Bad, Bim, Noxa, PUMA and the recently
identified Spike. These share sequence homology only
in the BH3 domain.
(3) Anti-apoptotic members such as Bcl-2, Bcl-xL and Bcl-w,
all of which exert anti-cell death activity and share
sequence conservation within all four BH domains. Many
of these members contain a hydrophobic carboxy
terminal domain, which targets them to intracellular
membranes such as the OMM, ER and nuclear envelopeFig. 1. Two models proposed for mitochondrial membrane permeabilisation. (A) C
cytosol of healthy cells. The release of Bax from its negative regulator 14-3-3q c
allowing Bax translocation from cytosol to mitochondria. Interaction of Bax with
Bax oligomerisation. The resultant pore formed requires four Bax molecules and
pass through this pore or if Bax can undergo further oligomerisation to form larg
translocate to mitochondria where it inserts into the OMM and induces a conform
protein Bcl-2 prevents tBid insertion, Bax translocation and Bax/Bak oligomerisati
proteins in mitochondrial locations such as the VDAC to form larger pores throu
such as AIF (57 kDa), endoG (30 kDa) and Omi/HtrA2 (50 kDa) are released. (B)
in the outer membrane, ANT in the inner membrane and cyclophilin D in the mat
membrane potential, an influx of fluid into the matrix which results in swelling an
intermembrane space. In this way, all soluble intermembrane proteins including
following disruption of mitochondrial integrity. Various inhibitors of the PTP
cyclophilin D) and Bongkrekic acid inhibit mitochondrial membrane permeabilisat
ANT, induces PTP opening and the release of pro-death factors. It is proposed that
PTP while anti-apoptotic members such as Bcl-2 and Bcl-xL favour closure of th[14]. Further recent evidence suggests that FKBP38, a
member of the immunophillin family, may be crucial in
targeting Bcl-2 and Bcl-xL to mitochondria [15].
The exact mechanism(s) by which Bcl-2 proteins protect
against or induce permeabilisation of the OMM is contro-
versial and still under intense investigation. At least two
models have been proposed, both of which involve mem-
bers of the Bcl-2 family (Fig. 1). Bcl-2 proteins themselves
may form channels in the OMM or they could interact with
and regulate pre-existing channels such as the Permeability
Transition Pore (PTP). These two mechanisms are not
necessarily mutually exclusive and may occur in a sequen-
tial fashion depending on cell type, stimulus and level of
stress. There is substantial evidence for and against both
models and this is discussed in several excellent reviewshannel formation by Bcl-2 family members. Bax is normally found in the
an occur by both caspase-dependent and caspase-independent mechanisms
tBid stimulates a conformational change in Bax, insertion to the OMM and
is capable of transporting cytochrome c. Whether or not larger proteins can
er channels remains to be elucidated. Following processing, tBid can also
ational change in Bak and Bak homo-oligomerisation. The anti-apoptotic
on in mitochondrial membranes. Alternatively, Bax could interact with other
gh which apoptogenic proteins involved in caspase-independent cell death
Opening of the PTP. The PTP is a complex primarily made up of the VDAC
rix. It is postulated that opening of the PTP results in loss of mitochondrial
d rupturing of the OMM and the release of pro-apoptotic proteins from the
caspase-independent factors such as Omi, endoG and AIF are released
that favour the closure of this channel including cyclosporin A (acts on
ion and in many instances cell death. Actractyloside, which is a ligand of the
pro-apoptotic Bcl-2 family members like Bax and Bak cause opening of the
is channel.
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compatible with the release of soluble intermembrane
proteins that play a role in caspase-independent cell death
and are therefore discussed below.3. Channel formation by Bcl-2 family members
The idea that Bcl-2 family members themselves form
channels in the OMM was originally based on the structural
similarity between Bcl-xL and the pore-forming domains of
several bacterial toxins, a key feature of which is the ability
to form ion channels in biological membranes [20]. Several
members of the Bcl-2 family such as Bax [21,22], Bcl-2
[23], Bcl-xL [24], and cleaved Bid [25] have since been
reported to form channels in artificial membranes.
Bax is probably the best studied and characterised pro-
apoptotic Bcl-2 protein that is capable of forming channels
under physiological conditions. Importantly, Bax is activated
in several instances of caspase-independent cell death, sup-
porting a role for Bax channels in the release of caspase-
independent death factors. Bax is normally found in the
cytosol of healthy cells and is reported to translocate to the
OMM in response to apoptotic stimuli and release intermem-
brane space proteins [26,27]. Bax translocation involves a
conformational change that exposes the amino and carboxyl
termini leading to mitochondrial translocation [28,29].
Cleavage of Bax is proposed to enhance its cell death
function [30]. In this way, cleavage of Bax at its N-terminus
by the calcium activated protease calpain is reported to
generate a potent pro-apoptotic 18-kDa fragment capable
of mediating cytochrome c release and apoptosis induced by
etoposide and staurosporine [31]. Oligomerisation of Bax
also appears to be required for channel formation [32]. This is
supported by several studies demonstrating that Bax forms
homo-oligomeric complexes in mitochondrial membranes
[33,34]. A recent study has also demonstrated that Bax
oligomerisation following mitochondrial insertion may trig-
ger a conformational change in resident Bak resulting in Bak
homo-oligomerisation, an event previously reported to be
mediated by Bid [35]. Overexpression of the anti-apoptotic
protein Bcl-2 not only prevents the oligomerisation of Bax
but also has been reported to inhibit both the Bax conforma-
tional change and mitochondrial translocation [28,33].
While Bax translocation and integration into the mito-
chondrial membrane in several apoptotic systems is well
established, the regulation of this translocation is poorly
understood and exactly how Bax remains inactive in healthy
cells is still ambiguous. Tsujimoto’s group [36] have recent-
ly improved our understanding of this mechanism in their
study describing the negative regulation of Bax by a
member of the 14-3-3 family, a group of proteins which
are implicated in apoptosis through their interaction with
pro-apoptotic molecules such as Bad. In the study carried
out by Tsujimoto’s group, 14-3-3q was found to interact
with Bax in the cytoplasm of living cells and Bax underwentdissociation from this protein by caspase-dependent and
independent mechanisms. These results suggest that 14-3-
3q may play a crucial role in the negative regulation of Bax
activity in living cells and more significantly demonstrate
that Bax translocation to mitochondria can occur indepen-
dently of caspase activation.
Oligomerisation and/or activation of Bak and Bax can
also be induced by Bid, a pro-apoptotic ‘BH3-only’ Bcl-2
family member. This mechanism is particularly important
during death receptor signalling as determined by the
inability of Bid deficient mice to undergo Fas-induced
hepatocellular apoptosis [37]. While some studies implicate
full-length Bid in the mitochondrial apoptotic pathway,
apoptotic signals that result in the processing of Bid to
truncated forms (tBid) result in a greatly improved inducer
of this pathway [38,39]. Caspase-8 was the first protease
shown to be responsible for Bid processing [40]. However,
it is now clear that cleavage of Bid can be achieved by
several other proteases in a caspase-independent manner,
including the serine protease Granzyme B (GrB) [41–43],
lysosomal proteases [44,45] and calpain [46,47]. Once
processed, tBid translocates to mitochondria and induces
mitochondrial membrane permeabilisation and the release
of apoptotic molecules. The mechanism by which tBid
causes the permeabilisation of the OMM is poorly defined.
One proposed mechanism is through interaction with Bax
or Bak [42,48–50]. tBid has increased affinity for Bax-like
factors and could act by stimulating the mitochondrial
insertion and oligomerisation of Bax/Bak. Alternative
mechanisms include channel-forming activity [25,51] or
interaction with the PTP complex. [52]. Multiple mecha-
nisms are also thought to be responsible for the suppression
of Bid-induced apoptosis by Bcl-2. While Bcl-2 does not
inhibit Bid processing or tBid translocation, this anti-
apoptotic protein does prevent tBid insertion, Bax translo-
cation and Bax/Bak oligomerisation in mitochondrial mem-
branes [53].
Regardless of the mechanism, it is widely accepted that
both Bax and tBid can induce mitochondrial membrane
permeabilisation. Clearly, the disruption of mitochondrial
integrity by these proteins can occur in a caspase-indepen-
dent manner as determined by the inability of caspase
inhibitors to prevent this phenomenon [54]. This is not
surprising considering calpains, lysosomal proteases and
GrB are all capable of processing Bid to produce tBid
and calpains can cleave Bax to generate another powerful
pro-death molecule, as previously mentioned. Additionally,
calpain activation has also been shown to result in Bcl-xL
cleavage [55]. Cleavage of Bcl-xL during the execution
phase of cell death has previously been shown to convert
Bcl-xL from a protective to a lethal protein [56,57]. The
pro-apoptotic activity of Bcl-xL elicited by proteolytic
cleavage could be due, at least in part, to enhanced pore
forming activity. This is supported by the demonstration
that C-terminal cleavage fragments of Bcl-xL, but not their
full-length anti-apoptotic counterpart, permeabilise both
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chrome c [58]. There is substantial evidence, therefore, in
favour of the production of potent death inducers and
resultant mitochondrial membrane permeabilisation in a
caspase-independent manner. If the Bcl-2 family regulate
outer membrane permeabilisation via their channel-forming
activities, the question remains: are these channels nonse-
lective, thereby allowing the passage of all soluble inter-
membrane proteins including caspase-independent pro-
death factors? If so, the pore formed must be large enough
to allow passage of relatively high molecular weight pro-
teins (e.g. AIF, 57 kDa). In relation to Bax-forming pores, it
has been demonstrated that purified Bax rapidly forms
membrane pores that release fluorescein-isothiocyanate-
conjugated cytochrome c (FITC-cytochrome c). The Bax
pore capable of transporting cytochrome c required four
Bax molecules and has an estimated pore size of 22 A˚,
theoretically not large enough to transport larger proteins
[59]. Would a sufficient density of Bax molecules in the
mitochondrial membrane form a pore large enough to
release other apoptosis promoting proteins? This would
require further oligomerisation, and such a channel has
yet to be identified in vivo. Additionally, it is possible that
Bax could interact with other proteins in mitochondrial
locations such as the voltage-dependent anion channel
(VDAC) to form larger pores. This theory continues to be
explored and is discussed later.
Evidence in favour of the formation of nonselective
channels comes from studies carried out on in a Xenopus
cell-free system [60]. Using this system, recombinant tBid
and Bax were found to induce the release of multiple
intermembrane proteins including, in addition to cyto-
chrome c, adenylate kinase (25 kDa), and sulfite oxidase
(104 kDa). Importantly, the ultrastructural morphology of
mitochondria remained unchanged, indicating that the re-
lease of these soluble factors does not require mitochondrial
swelling, a feature more characteristic of necrosis than
PCD. Further support comes from Vandenabeele’s group,
who recently undertook a matrix-assisted laser desorption
ionisation post-source decay (MALDI-PSD) analysis of
proteins released form isolated liver mitochondria treated
with recombinant truncated Bid [61]. Several mitochondrial
proteins were identified to be released including endoG,
Omi/HtrA2, Smac/Diablo and adenylate kinase-2. In con-
trast, the matrix protein adenylate kinase 3 was absent,
indicating that unlike soluble intermembrane proteins, ma-
trix proteins do not exit mitochondria, at least under these
conditions. In further support of the nonspecific release of
intermembrane proteins, Sutton et al. [62] have recently
demonstrated the release from mitochondria of the pro-
apoptotic mediators cytochrome c, Smac/Diablo, and
HtrA2/Omi. This study was carried out in GrB treated cells
and potentially involves tBid. These studies therefore sup-
port the conclusion that all intermembrane proteins that
have been measured are released in a tBid- or Bax-depen-
dent way.4. Bcl-2 regulation of the PTP
The PTP is a complex primarily made up of the VDAC in
the outer membrane, adenine nucleotide translocator (ANT)
in the inner membrane and cyclophilin D in the matrix. The
underlying mechanism behind the opening of this pore, its
involvement in apoptosis and the role of Bcl-2 proteins in its
regulation is under continuing debate. It is proposed that
pro-apoptotic Bcl-2 family members like Bax and Bak cause
opening of the PTP while anti-apoptotic members such as
Bcl-2 and Bcl-xL favour closure of this channel.
In support of the regulation of the PTP by Bcl-2 proteins,
Bax, Bak and Bcl-xL have been reported to interact directly
with the VDAC and modulate its activity [63,64], while Bax
and Bcl-2 have been reported to interact with ANT [65,66].
Recently, a direct interaction that is enhanced during apo-
ptosis has been reported between the BH3-only protein Bim
and VDAC [67]. In this study, Bim induced loss of mem-
brane potential and cytochrome c release and microinjection
of the anti-VDAC antibody significantly reduced Bim-in-
duced apoptosis, indicating that like Bax and Bak, Bim can
also directly activate the VDAC. In contrast, other BH3-only
proteins such as Bid (and its truncated form tBid) and Bik do
not bind to VDAC [68]. In further support of the regulation
of the PTP by Bcl-2 proteins, various inhibitors of the PTP
that favour the closure of this channel such as cyclosporin A,
Bongkrekic acid and Koenig’s polyanion abrogate cyto-
chrome c release and loss of membrane potential, effects
induced by addition of recombinant Bax to mitochondria
[65,69,70]. Cyclosporin A has also been shown to inhibit
apoptosis induced by overexpression of Bax in Jurkat T cells
[71]. Additional evidence for this model comes from Tsuji-
moto’s group who have demonstrated Bax/Bak-induced loss
in membrane potential and resultant cytochrome c release in
wild-type but not VDAC1-deficient yeast mitochondria [63].
This group was also the first to provide direct evidence that
the VDAC plays an essential role in apoptotic mitochondrial
changes and apoptosis in mammalian cells [72]. In this
study, anti-VDAC antibodies were employed to block
VDAC activity. These antibodies were found not only to
block Bax-induced cytochrome c release but, more signifi-
cantly, inhibited apoptosis induced by etoposide, paclitaxel,
and staurosporine. Of note, while these studies suggest that
VDAC is necessary for Bax-induced apoptosis in these
systems, they do not elucidate whether VDAC acts as a
channel or indeed functions as a receptor protein in the
mitochondrial membrane.
It is likely that the PTP plays a role in some apoptotic
systems and clearly there is considerable evidence in sup-
port of a role for Bcl-2 family members in the interaction
with and regulation of components of this complex. How is
the PTP involved in regulating mitochondrial membrane
permeability? One possible mechanism is the physical
rupture of the OMM. It is postulated that opening of the
PTP results in loss of mitochondrial membrane potential, an
influx of fluid into the matrix which results in swelling and
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proteins from the intermembrane space. This mechanism is
compatible with the hypothesis that all soluble intermem-
brane proteins including caspase-independent factors are
released following disruption of mitochondrial integrity.
Support for the nonselective nature of mitochondrial mem-
brane permeabilisation is provided by the demonstration that
supernatant from mitochondria treated with the PTP opening
agent actractyloside (a ligand of the ANT) contains multiple
soluble intermembrane proteins, including, in addition to
known apoptogenic factors, antioxidant enzymes, proteins
involved in protein import and catabolic enzymes [73]. This
study therefore confirms the nonselective nature of mito-
chondrial membrane permeabilisation due to PTP opening.
A recent report by Chang and Johnson [74] provides
additional evidence in favour of the involvement of the
PTP in caspase-independent cell death. This study demon-
strated that cyclosporin A (acts on cyclophilin D) inhibited
caspase-independent death of NGF-deprived sympathetic
neurons, suggesting that PTP opening is a critical event in
caspase-independent neuronal cell death, at least in this
system.
Another explanation for mitochondrial membrane perme-
abilisation is the release of pro-death molecules through
channels formed by interactions between individual compo-
nents of the PTP and Bcl-2 family members such as the
VDAC-Bax channel [75]. This model proposes that after
activation, Bax directly interacts with and forms a large pore
with the VDAC, through which apoptogenic proteins such as
cytochrome c are released [16]. In this way, Bax can trigger
caspase-dependent apoptosis. Whether or not larger proteins
involved in caspase-independent cell death such as AIF (57
kDa) and endoG (30 kDa) are released through the Bax-
VDAC channel remains to be elucidated. The majority of
studies on this channel has focussed exclusively on cyto-
chrome c release and therefore does not address the issue of
the translocation of other factors under these conditions. One
particular study has reported that Bax/VDAC liposomes
allow the passage of cytochrome c but are impermeable to
a 50-kDa protein [63]. How then is Smac/Diablo released?
This caspase co-activator acts as a multimeric protein with an
apparent molecular weight of 100 kDa [76]. It could be
argued that a prerequisite for caspase activation and caspase-
dependent apoptosis is the removal of IAP inhibition [77]
and it is likely therefore that Smac/Diablo is released along
with cytochrome c during apoptosis to counter the inhibitory
activity of IAPs and promote cytochrome c-dependent cas-
pase activation [76,78]. One would expect, therefore, that the
channel formed by the proposed VDAC-Bax interaction is at
least large enough to allow translocation of this protein.
Theoretically then, any soluble intermembrane protein with a
molecular weight of up to 100 kDa could be released through
this channel. This of course assumes that cytochrome c,
Smac/Diablo and other intermembrane proteins are released
via the same pathway. In support of this hypothesis, over-
expression of Bcl-2 not only inhibits the efflux of cyto-chrome c but also regulates the release of Smac/Diablo, AIF,
endoG and Omi/HtrA2, suggesting that these molecules may
exit via the same route [79–83]. Release kinetics studies of
these proteins may provide us with additional evidence as to
whether or not these intermembrane molecules are released
via the same pathway. There are conflicting reports, howev-
er, regarding the release kinetics of these proteins. For
example, the release of AIF precedes that of cytochrome c
in several models of apoptosis induction [69,81,84]. How-
ever, another report places AIF release downstream of
cytochrome c release [85]. In a similar way, the kinetics of
Smac/Diablo release from mitochondria in response to UV
treatment is the same as that of cytochrome c release [76,78],
again suggesting that the same mechanism responsible for
cytochrome c release is responsible for the translocation of
Smac/Diablo. In contrast, other reports suggest that Smac/
Diablo and cytochrome c may exit the mitochondria by
different pathways [86,87]. Omi/HtrA2 has been reported
to be released together with cytochrome c and Smac/Diablo
during apoptosis [88] and, similarly, both endoG and cyto-
chrome c are observed simultaneously in the supernatants of
tBid treated mitochondria [89]. The conflicting results re-
garding the release kinetics of AIF and Smac/Diablo may be
explained by the techniques employed, the affinity of the
antibodies used and the stimulus employed to induce mito-
chondrial membrane permeabilisation. Finally, although
similar release kinetics might suggest analogous exit routes,
different kinetics do not necessarily suggest distinct mech-
anisms of release but may imply the sequential action of a
shared pathway.5. Mitochondrial intermembrane proteins involved in
caspase-independent cell death
There is no doubt that pro-apoptotic Bcl-2 proteins such
as Bax and Bid play a crucial role in PCD via the induction
of OMM permeabilisation and the resultant efflux of
apoptogenic proteins. However, not only is the molecular
mechanism involved in this regulation under dispute but
also the exact proteins released. Is this family responsible
for the release of cytochrome c alone or do other pro-
apoptotic molecules translocate via the same or alternative
pathways?
Irrespective of the mechanism responsible for mitochon-
drial membrane permeabilisation, the release of proteins
from the mitochondrial intermembrane space appears to be
nonselective. The nonselective nature of mitochondrial
membrane permeabilisation is confirmed by the two recent
publications discussed above employing either the PTPC-
opening agent actractyloside or recombinant tBid and
isolated mitochondria [61,73]. In both studies, several
mitochondrial proteins belonging to a broad molecular mass
range were identified to be released and included several
proteins capable of mediating caspase-independent cell
death including relatively small proteins such as endoG
Fig. 2. Release of apoptogenic factors from mitochondria and their involvement in caspase-dependent and-independent cell death. Cleavage of Bid can be
achieved by several proteases including in addition to caspase-8, the serine protease GrB, lysosomal proteases and calpain. Once processed, tBid translocates to
mitochondria and induces mitochondrial membrane permeabilisation and the release of apoptotic molecules. These molecules may be released through Bax
channels (formed as a result of the interaction between tBid and Bax), channels incorporating Bax and various components of the PTP complex or as a result of
PTP opening, mitochondrial swelling and rupturing of the OMM (See Fig. 1). Regardless of the mechanism, several proteins are released from the
mitochondrial intermembrane space following disruption of mitochondrial integrity, and these proteins play crucial roles in both caspase-dependent and -
independent PCD. Cytochrome c, once released, associates with Apaf-1 to promote the activation of caspase-9, which can then activate caspase-3. Cleavage of
ICAD by caspase-3 triggers activation of the CAD endonuclease, which mediates oligonucleosomal DNA fragmentation (Stage II). GrB can also cleave ICAD
in a caspase-independent manner resulting in the activation of CAD. The caspase co-activator Smac/Diablo is released along with cytochrome c during
apoptosis to counter the inhibitory activity of IAPs and promote cytochrome c-dependent caspase activation. Smac/Diablo functions by binding IAPs such as
XIAP, thereby disrupting their ability to inhibit caspases 3, 7, and 9. On release to the cytosol, Omi has also been reported to bind XIAP, disrupting the
interaction of XIAP with caspase-9 resulting in caspase-9 activation. However, Omi can also induce caspase-independent cell death in mammalian cells
independently of its ability to interact with IAPs via its serine protease activity. While the underlying mechanism by which Omi induces caspase-independent
cell death is poorly understood, a specific inhibitor of the proteolytic activity of Omi dramatically reduces caspase-independent cell death. AIF, once released to
the cytosol, translocates to the nucleus in response to death stimuli and induces peripheral chromatin condensation and large-scale DNA fragmentation (Stage
I). AIF in association with a heat-labile cytosolic factor may also permeabilise mitochondrial membranes [81]. Finally, in response to apoptotic stimuli, endoG
is also released from the mitochondrion into the cytosol where it translocates to the nucleus and generates oligonucleosomal DNA fragmentation (Stage II).
Unlike caspase inhibitors, Bcl-2 effectively protects cells from both caspase-dependent and -independent apoptosis. This is more than likely through its ability
to prevent mitochondrial membrane permeabilisation and the resultant release of potent pro-apoptotic molecules.
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and the serine protease Omi/HtrA2 (50 kDa) (Fig. 2).6. AIF
AIF is a 57-kDa mitochondrial flavoprotein, which in
healthy cells resides in the mitochondrial intermembrane
space. A recent study demonstrating a vital role for AIF in
neuron survival in the ageing mouse brain has shed some
light on the function of AIF in normal cells [90]. This studywas carried out on Harlequin (Hq) mutant mice, which have
a proviral insertion in the AIF gene that results in an 80%
reduction in mRNA transcript and protein expression. This
loss of AIF leads to increased hydrogen peroxide sensitivity
that can be rescued by AIF transduction. Ackerman and
colleagues therefore propose that AIF acts as a free radical
scavenger, specifically acting on hydrogen peroxide. In
addition to this crucial antioxidant function in neurons,
AIF also displays apoptogenic activity and translocates to
the nucleus in response to death stimuli [84]. Once in the
nucleus, AIF induces peripheral chromatin condensation and
M. Donovan, T.G. Cotter / Biochimica et Biophysica Acta 1644 (2004) 133–147140large-scale DNA fragmentation [81,91]. These effects have
been reported to occur following addition of AIF to isolated
nuclei and upon microinjection of recombinant AIF protein
into cells. Additionally, AIF can affect mitochondria causing
a drop in the mitochondrial membrane potential and cyto-
chrome c release [69,81]. None of these AIF effects can be
prevented by addition of zVAD.fmk indicating that they are
caspase-independent [92]. Mitochondrial release of AIF has
been reported in several instances of caspase-independent
cell death induced by a variety of agents including, H2O2
[93], pneumococcus [94], cladribine [95], granulysin [96],
peroxynitrite [97], P53 [98], UVB [99], sulfasalazine [100]
and PARP-dependent cytotoxity induced by N-methyl-NV-
nitro-N-nitrosoguanidine, H2O2, and N-methyl-D-aspartate
[101]. The cell death in these systems is characterised
by various displays of apoptotic features including cell
shrinkage, cell surface exposure of phosphatidylserine, loss
of mitochondrial membrane potential and large-scale
DNA fragmentation, which cannot be prevented by caspase
inhibitors. AIF, therefore, appears to act as a lethal, caspase-
independent effector of apoptosis. Further evidence in sup-
port of the caspase-independent action of AIF comes from
studies carried out on the single cell organism Dictyostelium
discoideum [102]. Cell death in this organism is associated
with the release of the Dictyostelium homologue of AIF
(DdAIF) from the mitochondria and exhibits many features
of mammalian PCD including externalisation of PS, engulf-
ment of dying cells by neighbouring cells and fragmentation
of nuclear chromatin. Notably, this organism lacks clear
homologues of mammalian caspases.
Recently, definitive genetic evidence provided by Joza
et al. [103] establishes an essential role for AIF during early
mammalian development. Inactivation of AIF rendered
embryonic stem cells resistant to cell death induced by
serum withdrawal. Furthermore, AIF was found to be
essential for the first wave of PCD required for embryonic
morphogenesis and cavitation. Importantly, PCD required
for cavitation displayed typical apoptotic morphology, in-
cluding peripheral chromatin condensation, plasma mem-
brane blebbing, and formation of apoptotic bodies. An
essential function for AIF in C. elegans has also been
demonstrated [104]. Wang and colleagues employed RNA
interference to silence the C. elegans homologue of AIF
(wah-1) and found that in wah-1 RNAi-treated worms the
removal of apoptotic bodies was delayed, thus implicating
WAH-1 involvement in C. elegans PCD.
Significantly, AIF relocalisation from mitochondria to
the nucleus appears to be clinically relevant and has been
demonstrated to occur in vivo following traumatic brain
injury [97] and during photoreceptor apoptosis induced by
retinal detachment [105]. In both instances, DNA fragmen-
tation was detected and at least in the retinal detachment
model, administration of zVAD.fmk failed to prevent either
photoreceptor apoptosis or retinal functional damage. Inter-
estingly, this laboratory has also described a caspase-inde-
pendent pathway of photoreceptor apoptosis in vivo, whichcannot be prevented by zVAD.fmk and retains key charac-
teristics of apoptosis [11]. Rescue of photoreceptor degen-
eration by overexpression of Bcl-2 has been reported in this
model [106]. Targeting mitochondrial dysfunction, there-
fore, in diseases such as Retinitis Pigmentosa, where pho-
toreceptor apoptosis can occur independently of caspase
activation, may be of more therapeutic benefit than caspase
inhibitors. AIF itself may also represent an important
therapeutic target for protection against cell death. This is
supported by the crucial contribution of AIF to at least some
PCD pathways and is underscored by the effect of AIF
neutralising antibodies [81]. These antibodies have been
demonstrated to inhibit the effects of microinjected AIF
[69,81] and, importantly, AIF antisera significantly decrease
caspase-independent cell death induced by DNA damage
[98]. Intriguingly, HSP70 may also be a useful anti-apopto-
tic agent in conditions where caspase activation does not
occur, due to its ability to interact with AIF, and protects
cells against death induced by AIF overexpression, staur-
osporine and menadione [107]. The same may also be true
for the treatment of cancer. Classic therapeutic strategies
often target caspase-dependent apoptosis; however, many
cancer cells are resistant to apoptotic stimuli that induce
caspase-dependent cell death. This is true in relation to lung
cancer cells that are resistant to a broad spectrum of
apoptotic stimuli, including receptor stimulation, cytotoxic
drugs and gamma-radiation. Triggering an AIF-mediated
caspase-independent pathway as recently described by Jo-
seph et al. [108] may circumvent the resistance of these cells
to treatment.
Exactly how AIF exerts its functions remains elusive. It
has recently been suggested that AIF-induced nuclear apo-
ptosis requires a direct interaction with DNA [109]. This
study revealed the crystal structure of human AIF, revealing
a positive electrostatic potential and interaction of AIF with
DNA in a sequence-independent manner. More importantly,
AIF mutants lacking DNA-binding ability failed to induce
cell death while retaining nuclear translocation. The recent
cloning of the C. elegans homologue of AIF (wah-1) and
investigation into the mechanisms by which it mediates
apoptosis in the nematode have led to the proposal that AIF
may cooperate with endoG to promote DNA degradation
[104]. In this study, WAH-1 and CPS-6 (the worm ortho-
logue of mammalian endoG) were found to interact in vitro
and cooperate together to efficiently degrade DNA in a
concentration-dependent manner. Importantly, coexpression
of csp6 and wah-1 in touch receptor neurons had a syner-
gistic effect on cell killing, further supporting the conclusion
that these proteins cooperate to promote DNA degradation
and cell death. It has yet to be determined whether mam-
malian AIF can cooperate with endoG or indeed other
proteins to promote apoptosis in mammalian cells.
The mechanism(s) responsible for AIF release from the
mitochondrial intermembrane space are still unclear and
whether or not it is released via the same pathway as
cytochrome c remains to be elucidated. However, there is
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and subsequent caspase-independent cell death. Overexpres-
sion of Bcl-2 in a variety of systems inhibits the mitochon-
drial release of AIF and cell death. These include apoptosis
induced by granulysin [96], TNFa [110], cladribine [95],
TRAIL [111], overexpression of AIF constructs [91], staur-
osporine [81,84] and camptothecin in Apaf / neurons
[98]. Bax has also been reported to play a role in the
regulation of AIF release. Translocation of Bax to mito-
chondria and subsequent AIF release has been described in
several systems including hypothyroidism during rat cere-
bellar development [112] and apoptosis of Env-induced
syncytia [69]. Bax expression leads to an increase in AIF
efflux from mitochondria [85]. Furthermore, Bax has been
shown to mediate mitochondrial depolarisation and AIF
release in neurons [98]. In this study, camptothecin was
found to induce AIF release in Bax+/ + neurons but not in
neurons deficient of Bax (Bax /). tBid is also associated
with AIF release and cleavage of Bid has been demonstrated
to occur in conjunction with AIF translocation from mito-
chondria to the nucleus [110,111]. Furthermore, treatment of
isolated liver mitochondria with truncated Bid results in AIF
release [113]. Finally, the genetic data obtained from C.
elegans add further support to the regulation of AIF release
by Bcl-2 family members. In a similar way to AIF, WAH-1
localises to the mitochondria, and is released to promote
DNA fragmentation. Significantly, global expression of
EGL-1 (the nematode homologue of the mammalian pro-
apoptotic ‘BH-3 only’ subfamily) causes the release of
WAH-1 from mitochondria [104]. Therefore, the pro-apo-
ptotic function of AIF and the regulation of its release by
Bcl-2 family members may represent an evolutionary con-
served pathway to DNA degradation and cell death.7. EndoG
While AIF translocation to the nucleus is associated with
large-scale fragmentation of DNA (f 50 kb), apoptotic
DNA cleavage can occur in two stages and this initial
large-scale cleavage may be followed by a second stage of
oligonucleosomal DNA fragmentation (DNA laddering).
The best characterised endonuclease to date capable of
inducing both chromatin condensation and DNA fragmen-
tation is caspase activated DNase (CAD) [114]. CAD
requires cleavage of its inhibitor, ICAD, by caspase-3 for
nuclease activity [115]. However, in cells lacking caspase-3,
ICAD can still be cleaved in response to apoptotic stimuli,
suggesting that caspases other than caspase-3 or indeed
other proteases may also cleave this inhibitor and induce
DNA fragmentation [116]. In this way, GrB has been shown
to induce DNA fragmentation in the presence of broad range
caspase inhibitors [117]. Direct cleavage of ICAD by GrB in
a caspase-independent manner has also been demonstrated
both in vitro and in vivo and mutational analysis has
revealed a common cleavage site of caspase-3 and GrBfor ICAD processing [118]. These studies provide a cas-
pase-independent pathway for GrB in mediating apoptotic
cell death.
It is now evident, however, that other endonucleases may
be essential for DNA fragmentation, particularly during
caspase-independent apoptosis. The involvement of endo-
nucleases other than CAD in apoptosis is supported by a
recent report demonstrating oligonucleosomal DNA frag-
mentation in ICAD knockout mice after traumatic brain
injury [119]. Additionally, transgenic mice expressing a
caspase-resistant mutant ICAD develop normally and ex-
hibit residual DNA fragmentation [120]. These studies
indicate that CAD is not the only DNase implicated in
apoptosis. One alternative endonuclease is endoG, a mito-
chondrial enzyme originally proposed to participate in the
replication of mitochondrial DNA [121]. Unlike CAD,
endoG does not require cleavage for activation but is
activated by a change in its subcellular localisation. Origi-
nally believed to be a matrix protein due to its proposed
involvement in mitochondrial DNA replication, repair and
degradation, recent data describe the exclusive location of
endoG within the mitochondrial intermembrane space [122].
This location is necessary in order for it to participate in
DNA degradation as mitochondria in cells undergoing
apoptosis retain most matrix proteins. In response to apo-
ptotic stimuli, endoG is released from the mitochondrion
into the cytosol where it translocates to the nucleus and
generates oligonucleosomal DNA fragmentation [89].
EndoG-induced DNA fragmentation occurs independently
of caspase activation [82,89]. The release of endoG from
mitochondria was originally described by Li et al. [89]
following treatment of isolated mitochondria with tBid.
Importantly, in this study, mitochondrial efflux of endoG
was not observed in Bcl-2 transgenic mice indicating that
the Bcl-2 family may be involved in the regulation of endoG
release. Shortly after this discovery, the in vivo occurrence
of endoG release from mitochondria was reported during
Fas-induced apoptosis in the liver [82].
The nematode counterpart of endoG, CPS-6, also cleaves
DNA into nucleosomal sized fragments and was the first
mitochondrial protein identified to be involved in PCD in C.
elegans [123]. This study also provides the first genetic
evidence that DNA degradation is an important component
of cell death execution. Loss of CPS-6 activity actually
delays the progression of apoptosis, indicating that CPS-6
may contribute to cell killing. The finding that mammalian
endoG can replace the function of CSP-6 in the nematode,
together with their identical subcellular localisation and
DNA degradation properties, may be indicative of an
evolutionary conserved DNA degradation pathway.8. Omi/HtrA2
Omi/HtrA2 is a novel mammalian serine protease that
has extensive homology to the bacterial HtrA (high tem-
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bacteria, HtrA has a dual role, acting as chaperone at
normal temperatures and an active protease at elevated
temperatures [125]. Mammalian Omi, similar to endoG
and AIF, exhibits pro-apoptotic activity and resides in
mitochondria of healthy cells and is released to the cytosol
on apoptotic stimulus [88,126]. The translocation of Omi
from mitochondria to cytosol has also been confirmed in
vivo [80]. In this study, administration of anti-Fas anti-
bodies to mice induced the release of Omi from liver
mitochondria. The subcellular localisation of this intermem-
brane protein appears to be under the regulation of Bcl-2
proteins. tBid induces release of mitochondrial processed
Omi while Bcl-2 completely prevents this event
[80,88,126]. Recently, Bax has also been demonstrated to
play a pivotal role in the control of Omi release from
mitochondria [127]. In this study, treatment of human colon
cancer cells with thapsigargin resulted in a conformational
change in Bax, mitochondrial translocation and the release
of Omi together with cytochrome c and Smac/Diablo into
the cytosol. Importantly, the absence of Bax blocked the
thapsigargin-induced efflux of these proteins, indicating that
Bax is essential for mitochondrial permeabilisation and Omi
release in this system.
Moderate expression levels of Omi can sensitise cells to
UV and staurosporine induced apoptosis while higher levels
can induce apoptosis even in the absence of apoptotic insult
[88,126,128]. In addition, removal of endogenous Omi by
RNA interference results in a significant reduction in cell
death [126]. The pro-apoptotic activity of Omi is attributed
to both its serine protease activity and its ability to antag-
onise IAPs. There is some evidence that Omi functions as an
IAP inhibitor thereby inducing caspase-dependent apoptosis
in a manner similar to Smac/Diablo. Omi protein is synthe-
sized as a precursor that is processed in the mitochondria to
produce the mature protein. Processing exposes an internal
tetrapeptide at the amino terminus. Smac/Diablo and the
Drosophila IAP antagonists Reaper, Grim and Hid share a
similar sequence motif, the Reaper Grim Hid (RGH) motif,
that is sufficient to bind IAPs. On release to the cytosol,
Omi has been reported to bind XIAP through this RGH
domain, disrupting the interaction of XIAP with caspase-9,
resulting in caspase-9 activation [88,126]. Omi has also
been reported to antagonise XIAP inhibition of caspase-3 in
vitro [83]. The N-terminal IAP-binding motif is essential for
its ability to bind IAPs [83,88].
Omi can also induce caspase-independent cell death in
mammalian cells independently of its ability to interact
with IAPs via its serine protease activity [88,128]. This is
supported by a recent study demonstrating that UV treat-
ment results in the release of Omi into the cytosol, an event
that cannot be prevented by zVAD.fmk. These results
suggest that translocation of Omi from mitochondria to
cytosol does not depend on caspase activity [88]. However,
the underlying mechanism by which Omi induces caspase-
independent cell death is poorly understood and remains tobe elucidated. The demonstration that Omi can process
itself to generate an RGH domain at the N-terminus leads
to some speculation that it may be capable of cleaving
other proteins to reveal similar motifs [126]. It is also
possible that Omi could act on the nucleus as the processed
form of this protein has been detected there [129]. Future
identification of the physiological substrates for Omi will
significantly contribute to our understanding of the mech-
anism by which Omi induces cell death. Very recently, a
specific inhibitor of the proteolytic activity of Omi was
identified and found to dramatically reduce caspase-inde-
pendent cell death induced by overexpression of Omi
[130]. This inhibitor or similar Omi specific inhibitors will
also help us to elucidate the role of Omi in caspase-
independent cell death.9. Conclusion
Caspases appear to provide a critical function in devel-
opmental cell death observed in C. elegans and Drosophila.
However, in contrast to these classical examples of caspase-
dependent cell death, the studies discussed here reporting
caspase-independent apoptosis indicate that at least in these
models, many of the apoptotic features observed are not
regulated by caspase activation. Such features include
cytoplasmic and nuclear shrinkage, mitochondrial depolar-
isation, peripheral chromatin condensation and, in some
instances, oligonucleosomal DNA fragmentation. Further-
more, there are now several examples of cells surviving the
activation of caspases, suggesting that caspases alone are
not sufficient for the induction of apoptosis [131,132].
Although there is increasing evidence to support a role
for proteases other than caspases such as calpains, cathe-
psins, and GrB as molecular regulators of caspase-indepen-
dent cell death, mitochondria also play a central role in this
process by releasing several death-promoting factors. While
cytochrome c is probably the best characterised protein to
translocate from mitochondria to the cytosol, it is now
evident that several other apoptotic proteins including
AIF, Omi and endoG reside within the mitochondrion and
are released following the death stimulus. It is clear that the
nuclear events as well as some of the cytosolic features
observed during apoptosis can be mediated in a caspase-
independent manner by some of the proteins mentioned
above. Mitochondrial membrane perforation, therefore, not
only serves to induce caspase-dependent apoptosis but also
a caspase-independent cell death pathway. Regarding the
underlying mechanism responsible for the release of pro-
teins that mediate apoptotic features independently of
caspase activation, at present there is limited data contrary
to the view that these proteins exit mitochondria via the
same pathway as cytochrome c. The resultant cell death
pathway is likely to be dependent on the presence of post-
mitochondrial caspase-dependent factors such as caspases
themselves or Apaf-1. Under conditions where these factors
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ensue, mediated at least by some of the proteins discussed
previously.
Regardless of the pathway(s) and mechanism(s) in-
volved, there is little doubt that the release of these pro-
death factors requires mitochondrial membrane permeabili-
sation, an event that is undisputedly regulated by members
of the Bcl-2 family. As the control of mitochondrial integrity
by this family is common to both caspase-dependent and-
independent apoptosis, therapeutic strategies which target
Bcl-2 proteins may be extremely beneficial for cancer and
degenerative diseases where both pathways can contribute
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